581 related articles for article (PubMed ID: 10673944)
1. First trimester nuchal translucency: effective routine screening for Down's syndrome.
Thilaganathan B; Sairam S; Michailidis G; Wathen NC
Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
[TBL] [Abstract][Full Text] [Related]
2. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
Thilaganathan B; Slack A; Wathen NC
Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
[TBL] [Abstract][Full Text] [Related]
3. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
[TBL] [Abstract][Full Text] [Related]
4. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
[TBL] [Abstract][Full Text] [Related]
5. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
[TBL] [Abstract][Full Text] [Related]
6. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
[TBL] [Abstract][Full Text] [Related]
7. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.
Adekunle O; Gopee A; el-Sayed M; Thilaganathan B
Br J Radiol; 1999 May; 72(857):457-60. PubMed ID: 10505009
[TBL] [Abstract][Full Text] [Related]
8. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of fetal nuchal translucency.
Jackson M; Rose NC
Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
[TBL] [Abstract][Full Text] [Related]
10. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome.
Wald NJ; Hackshaw AK
Prenat Diagn; 1997 Sep; 17(9):821-9. PubMed ID: 9316126
[TBL] [Abstract][Full Text] [Related]
11. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
Hafner E; Schuchter K; Philipp K
Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
[TBL] [Abstract][Full Text] [Related]
12. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
Chasen ST; Sharma G; Kalish RB; Chervenak FA
Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
[TBL] [Abstract][Full Text] [Related]
13. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
14. The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome.
Kadir RA; Economides DL
Ultrasound Obstet Gynecol; 1997 Apr; 9(4):244-7. PubMed ID: 9168574
[TBL] [Abstract][Full Text] [Related]
15. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
Josefsson A; Molander E; Selbing A
Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
[TBL] [Abstract][Full Text] [Related]
16. Influence of ethnic origin on nuchal translucency screening for Down's syndrome.
Thilaganathan B; Khare M; Williams B; Wathen NC
Ultrasound Obstet Gynecol; 1998 Aug; 12(2):112-4. PubMed ID: 9744055
[TBL] [Abstract][Full Text] [Related]
17. The distribution of nuchal translucency at 10-13 weeks of pregnancy.
Schuchter K; Wald N; Hackshaw AK; Hafner E; Liebhart E
Prenat Diagn; 1998 Mar; 18(3):281-6. PubMed ID: 9556045
[TBL] [Abstract][Full Text] [Related]
18. First-trimester Down's syndrome screening using nuchal translucency: a prospective study in patients undergoing chorionic villus sampling.
Brambati B; Cislaghi C; Tului L; Alberti E; Amidani M; Colombo U; Zuliani G
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):9-14. PubMed ID: 7850598
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of a programme for the prenatal screening for Down's syndrome by ultrasonographic nuchal translucency measurement and serum determinations in the first trimester of pregnancy].
Go AT; Hupkes HW; Lomecky M; Twisk J; Blankenstein JM; van Vugt JM
Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2795-9. PubMed ID: 16385832
[TBL] [Abstract][Full Text] [Related]
20. Increased nuchal translucency as a marker for fetal chromosomal defects.
Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]